Cohance Lifesciences Limited (COHANCE.BO)
Cohance Lifesciences Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Hyderabad, TS, IN. The stock last traded at $441.00, down 0.77% on the session, giving a market capitalisation of $168.35B. Its beta of 0.60 implies it has historically moved less than the broad market.
Headquartered in Hyderabad, Cohance Lifesciences Limited is a pharmaceutical company with a core focus on providing contract development and manufacturing (CDMO) services, developing active pharmaceutical ingredients (APIs), and manufacturing specialty chemicals. This entity was formerly known as Suven Pharmaceuticals Limited but underwent a rebranding to its current name following its integration with Cohance Lifesciences, a transition that became effective on May 1, 2025.
Cohance Lifesciences Limited is most often compared with the following Healthcare names: